Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,501 | -22,826 | -6,531 | -18,916 | -21,516 |
| Depreciation Amortization | 1,113 | 743 | 377 | 1,325 | 945 |
| Other Working Capital | -1,379 | -3,193 | -1,197 | -2,099 | -3,288 |
| Other Operating Activity | 30,678 | 10,485 | -229 | -17,861 | -5,765 |
| Operating Cash Flow | $-19,089 | $-14,791 | $-7,580 | $-37,551 | $-29,624 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -490 | -248 | -99 | -1,879 | -1,956 |
| Investing Cash Flow | $-490 | $-248 | $-99 | $-1,879 | $-1,956 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 10,000 | 10,000 | 34,889 | 34,889 |
| Common Stock Issued | N/A | N/A | 0 | 130 | 130 |
| Other Financing Activity | -46 | -14 | -14 | -61 | -61 |
| Financing Cash Flow | $24,954 | $9,986 | $9,986 | $34,958 | $34,958 |
| Beginning Cash Position | 14,771 | 14,771 | 14,771 | 19,243 | 19,243 |
| End Cash Position | 20,146 | 9,718 | 17,078 | 14,771 | 22,621 |
| Net Cash Flow | $5,375 | $-5,053 | $2,307 | $-4,472 | $3,378 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,089 | -14,791 | -7,580 | -37,551 | -29,624 |
| Capital Expenditure | -490 | -248 | -99 | -1,879 | -1,956 |
| Free Cash Flow | -19,579 | -15,039 | -7,679 | -39,430 | -31,580 |